Singapore, Sept. 29 -- South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that its AI-powered mammography solution, Lunit INSIGHT MMG, will be implemented as an independent second reader across the entire Stockholm Region in Sweden, building on years of successful clinical validation and real-world use at Capio Saint Goran Hospital.

The deployment, carried out in collaboration with Sectra, will span three institutions: Capio Saint Goran Hospital, Karolinska University Hospital, and Sodersjukhuset (Sos). Once fully implemented, the deployment is expected to support between 200,000 and 250,000 examinations annually.

The Stockholm deployment follows Lunit's earlier regional deploy...